Search News
| 374.26 Delayed Data As of Aug 17 |  +2.48 / +0.67%Today’s Change | 281.89 Today|||52-Week Range 505.49 | -0.45% Year-to-Date |
| Previous close | 371.78 |
| Today’s open | 373.00 |
| Day’s range | 370.17 - 377.86 |
| Volume | 669,593 |
| Average volume (3 months) | 858,075 |
| Market cap | $38.4B |
| Earnings growth (last year) | +34.29% |
| Earnings growth (this year) | +24.42% |
| Earnings growth (next 5 years) | +9.96% |
| Revenue growth (last year) | +20.82% |
| P/E ratio | 27.1 |
| Price/Sales | 7.42 |
| Price/Book | 6.34 |
| Today’s change | Today’s % change | |
|---|---|---|
| SHPGShire | -1.08 | -0.63% |
| VRTXVertex Pharmaceutica... | +1.12 | +0.64% |
| BAXBaxter International... | +0.46 | +0.64% |
| ALXNAlexion Pharmaceutic... | -1.28 | -1.09% |
| Next reporting date | November 6, 2018 |
| EPS forecast (this quarter) | $5.13 |
| Annual revenue (last year) | $5.9B |
| Annual profit (last year) | $1.2B |
| Net profit margin | 20.41% |
Sector Health Technology |
Industry Biotechnology |
Co-President, Chief Executive Officer & Director Leonard S. Schleifer |
Co-President, Director & Chief Scientific Officer George Damis Yancopoulos |
Corporate headquarters Tarrytown, New York |
